journal article·2016-12-14

Magnetic Tandem Apoptosis for Overcoming Multidrug-Resistant Cancer

Mi Hyeon Cho, Seulmi Kim, Jae-Hyun Lee, Tae-Hyun Shin, Dongwon Yoo, Jinwoo Cheon

Nano Letters· Volume 16· Issue 12
Publisher page

Abstract

Multidrug resistance (MDR) is a leading cause of failure in current chemotherapy treatment and constitutes a formidable challenge in therapeutics. Here, we demonstrate that a nanoscale magnetic tandem apoptosis trigger (m-TAT), which consists of a magnetic nanoparticle and chemodrug (e.g., doxorubicin), can completely remove MDR cancer cells in both in vitro and in vivo systems. m-TAT simultaneously activates extrinsic and intrinsic apoptosis signals in a synergistic fashion and downregulates the drug efflux pump (e.g., P-glycoprotein) which is one of the main causes of MDR. The tandem apoptosis strategy uses low level of chemodrug (in the nanomolar (nM) range) to eliminate MDR cancer cells. We further demonstrate that apoptosis of MDR cancer cells can be achieved in a spatially selective manner with single-cell level precision. Our study indicates that nanoscale tandem activation of convergent signaling pathways is a new platform concept to overcome MDR with high efficacy and specificity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Drug Transport and Resistance Mechanisms · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Nanomedicine, Institute for Basic Science (IBS), Seoul 03722, Republic of Korea

Yonsei-IBS Institute, Yonsei University, Seoul 03722, Republic of Korea

Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea

Funding

Ministry of Health and Welfare · Institute for Basic Science

References (32)

Show source-provided references
1. 10.1038/nrc77610.1038/nrc776 ↗
2. 10.1038/nrd266210.1038/nrd2662 ↗
3. 10.1038/sj.onc.120960810.1038/sj.onc.1209608 ↗
4. 10.1038/nrc82110.1038/nrc821 ↗
5. 10.1016/j.ctrv.2008.11.00610.1016/j.ctrv.2008.11.006 ↗
6. 10.1038/nrc70610.1038/nrc706 ↗
7. 10.1038/nrc359910.1038/nrc3599 ↗
8. 10.1038/nrd198410.1038/nrd1984 ↗
9. 10.1016/S0006-2952(99)00139-210.1016/S0006-2952(99)00139-2 ↗
10. 10.1073/pnas.89.13.582410.1073/pnas.89.13.5824 ↗
11. 10.1021/ja409886210.1021/ja4098862 ↗
12. 10.1016/j.bcp.2012.01.00810.1016/j.bcp.2012.01.008 ↗
13. 10.1016/j.jconrel.2011.01.02410.1016/j.jconrel.2011.01.024 ↗
14. 10.1021/ja410828710.1021/ja4108287 ↗
15. 10.1002/anie.20130998510.1002/anie.201309985 ↗
16. 10.1002/adma.20100316210.1002/adma.201003162 ↗
17. 10.1002/anie.20150432910.1002/anie.201504329 ↗
18. 10.1002/anie.20150715710.1002/anie.201507157 ↗
19. 10.1073/pnas.080537410510.1073/pnas.0805374105 ↗
20. 10.1023/A:100648700381410.1023/A:1006487003814 ↗
21. 10.1021/nn405632s10.1021/nn405632s ↗
22. 10.1038/nmat343010.1038/nmat3430 ↗
23. 10.1002/anie.20080514910.1002/anie.200805149 ↗
24. 10.1002/anie.20100114910.1002/anie.201001149 ↗
25. 10.1021/bc900201910.1021/bc9002019 ↗
26. 10.1021/ja207463b10.1021/ja207463b ↗
27. 10.1038/nmat350110.1038/nmat3501 ↗
28. 10.1038/nnano.2007.41810.1038/nnano.2007.418 ↗
29. 10.1186/1476-4598-9-19910.1186/1476-4598-9-199 ↗
30. 10.1016/j.bbadis.2011.04.00410.1016/j.bbadis.2011.04.004 ↗
31. 10.1002/jcp.2062810.1002/jcp.20628 ↗
32. NCSS Statistical Software Home Page. PASS14 (Power Analysis and Sample Size) Software.https://www.ncss.com/software/pass/(accessed Oct. 6, 2016) .